GBM cells secrete receptor activator of nuclear factor kappa beta (RANKL) which activates the nuclear factor kappa-light-chain-enhancer of the activated B cells (NF-κB) signalling pathway through binding to NF-κB receptors heavily expressed in peripheral GBM tumours. The gene discussed is NFKB1; the disease is glioblastoma.